Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5036358013 | Itopride hydrochloride 150 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5036359017 | Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Is a | Product containing only itopride and pantoprazole in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Gastro-resistant and prolonged-release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Itopride hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has basis of strength substance | Itopride hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Pantoprazole sodium | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has basis of strength substance | Pantoprazole | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely itopride hydrochloride 150 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR